SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 8.11 |
| Enterprise Value ($M) | 5.77 |
| Book Value ($M) | 8.00 |
| Book Value / Share | 0.47 |
| Price / Book | 1.01 |
| NCAV ($M) | -0.82 |
| NCAV / Share | -0.05 |
| Price / NCAV | -9.91 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.90 |
| Return on Assets (ROA) | -0.45 |
| Return on Equity (ROE) | -0.80 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.56 |
| Current Ratio | 3.56 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 9.42 |
| Assets | 18.24 |
| Liabilities | 10.23 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -15.25 |
| Net Income | -13.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -12.68 |
| Cash from Investing | 3.78 |
| Cash from Financing | 12.04 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Rosalind Advisors, Inc. | 9.90 | ||
| 13D/A | Nantahala Capital Management, LLC | 11.70 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 6,171 | 27,411 | 22.51 | |
| 14,886 | 41,482 | 35.89 | |
| 43,113 | 83,755 | 51.48 | |
| 1,363 | 31,087 | 4.38 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TBPH – Theravance Biopharma, Inc. | TCRX – TScan Therapeutics, Inc. |
| TKNO – Alpha Teknova, Inc. | TNGX – Tango Therapeutics, Inc. |
| TRDA – Entrada Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io